GeneDx Holdings (WGS) Total Debt Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -0.37% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 81.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.32% |
| Mar 31, 2026 | 80.34% |
| Dec 31, 2025 | -7.20% |
| Sep 30, 2025 | 5.41% |
| Jun 30, 2025 | 5.73% |
| Mar 31, 2025 | 6.04% |
| Dec 31, 2024 | -1.47% |
| Sep 30, 2024 | 759.78% |
| Jun 30, 2024 | 734.56% |
| Mar 31, 2024 | 394.96% |
| Dec 31, 2023 | 435.28% |
| Sep 30, 2023 | -51.50% |
| Jun 30, 2023 | -53.20% |
| Mar 31, 2023 | -25.79% |
| Dec 31, 2022 | -27.75% |
| Sep 30, 2022 | 0.43% |
| Jun 30, 2022 | -30.83% |
| Mar 31, 2022 | -26.23% |
| Dec 31, 2021 | -33.21% |